Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation

Lung Cancer

Volumn 68, Issue 3, 2010, Pages 394-397

  Li, Minghuan ^a   Sun, Yun ^b   Liu, Yuhui ^a   Han, Anqin ^a   Zhao, Shuqiang ^a   Ma, Li ^a   Zheng, Jinsong ^a   Yu, Jinming ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Deoxyglucose; Histology type; Lung neoplasms; Position emission tomography; Stage

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DEOXYGLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TUMOR VOLUME; ADENOCARCINOMA; COMPARATIVE STUDY; LUNG TUMOR; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RADIOGRAPHY; SPECTROMETRY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DEOXYGLUCOSE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SPECTROMETRY, X-RAY EMISSION;

EID: 77952546120     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.07.009     Document Type: Article

References (21)

1. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002, 122(3):1037-1057.
2. Detterbeck F.C., Vansteenkiste J.F., Morris D.E., Dooms C.A., Khandani A.H., Socinski M.A. Seeking a home for a PET. Part 3. Emerging applications of positron emission tomography imaging in the management of patients with lung cancer. Chest 2004, 126(5):1656-1666.
3. Vansteenkiste J., Fischer B.M., Dooms C., Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 2004, 5:531-540.
4. Hicks R.J., Kalff V., MacManus M.P., Ware R.E., McKenzie A.F., Matthews J.P., et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 2001, 42(11):1596-1604.
5. Weber W.A., Petersen V., Schmidt B., Tyndale-Hines L., Link T., Peschel C., et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 2003, 21(14):2651-2657.
6. Schrevens L., Lorent N., Dooms C., Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 2004, 9(6):633-643. Review.
7. Cerfolio R.J., Bryant A.S., Ohja B., Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005, 130(1):151-159.
8. Sasaki R., Komaki R., Macapinlac H., Erasmus J., Allen P., Forster K., et al. [18F]fluoro-deoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 2005, 23(6):1136-1143.
9. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., De Leyn P.R., Verbeken E.K., Deneffe G.J., et al. Prognostic importance of the standardized uptake value on FDG-PET-scan in non-small cell lung cancer: an analysis of 125 cases. J Clin Oncol 1999, 17:3201-3206.
10. Higashi K., Ueda Y., Arisaka Y., Sakuma T., Nambu Y., Oguchi M., et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 2002, 43:39-45.
11. Downey R.J., Akhurst T., Gonen M., Vincent A., Bains M.S., Larson S., et al. Preoperative F-18fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004, 22:3255-3260.
12. Ohtsuka T., Nomori H., Watanabe K., Kaji M., Naruke T., Suemasu K., et al. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer 2006, 107:2468-2473.
13. Zhang Z.J., Chen J.H., Meng L., Du J.J., Zhang L., Liu Y., et al. 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer. Chin Med J 2007, 120:125-131.
14. Higashi K., Ueda Y., Yagishita M., Arisaka Y., Sakurai A., Oguchi M., et al. FDG-PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 2000, 41:85-92.
15. Nguyen X.C., Lee W.W., Chung J.H., Park S.Y., Sung S.W., Kim Y.K., et al. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Eur J Radiol 2007, 62:214-219.
16. Duhaylongsod F.G., Lowe V.J., Patz E.F., Vaughn A.L., Coleman R.E., Wolfe W.G. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxy glucose positron emission tomography. Ann Thorac Surg 1995, 60:1348-1352.
17. Guo J., Higashi K., Ueda Y., Oguchi M., Takegami T., Toga H., et al. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. J Nucl Med 2006, 47(3):419-425.
18. de Geus-Oei L.F., van Krieken J.H., Aliredjo R.P., Krabbe P.F., Frielink C., Verhagen A.F., et al. Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007, 55:79-87.
19. Wang T., Sun Y., Zhou N., Yao S., Wang R., Yin D. Fluorine-18fluorodeoxyglucose uptake in patients with primary lung cancer. Chin J Surg 2002, 40(6):437-440.
20. Hara T., Kosaka N., Suzuki T., Kudo K., Niino H. Uptake rates of 18F-fluorodeox-yglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest 2003, 124(3):893-901.
21. Jeong H.J., Min J.J., Park J.M., Chung J.K., Kim B.T., Jeong J.M., et al. Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 2002, 23(9):865-870.